tradingkey.logo
tradingkey.logo
Search

SI-BONE Inc

SIBN
Add to Watchlist
14.160USD
-0.440-3.01%
Close 05/15, 16:00ETQuotes delayed by 15 min
625.89MMarket Cap
LossP/E TTM
View Detailed Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-3.01%

5 Days

+15.40%

1 Month

+3.58%

6 Months

-18.71%

Year to Date

-28.19%

1 Year

-28.45%

TradingKey Stock Score of SI-BONE Inc

Currency: USD Updated: 2026-05-15

Key Insights

SI-BONE Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 9 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 24.00.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

SI-BONE Inc's Score

Industry at a Glance

Industry Ranking
9 / 206
Overall Ranking
71 / 4482
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

SI-BONE Inc Highlights

StrengthsRisks
SI-BONE, Inc. is a medical device company dedicated to solving musculoskeletal disorders of sacropelvic anatomy. The Company specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The Company's products include a series of patented titanium implants, and the instruments used to implant them, as well as implantable bone products. Its products include iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite. Within the United States, iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. Its first-generation iFuse, a machined triangular titanium implant, has a triangular cross section that resists twisting or rotation of the implant. The Company's second generation iFuse product, the iFuse-3D implant, is a patented titanium implant.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 44.67% year-on-year.
Undervalued
The company’s latest PE is -36.86, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 45.75M shares, decreasing 4.78% quarter-over-quarter.
Held by PRFDX
Star Investor PRFDX holds 3.97K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.76.

Analyst Rating

Based on 9 analysts
Buy
Current Rating
24.000
Target Price
+69.49%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

SI-BONE Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

SI-BONE Inc Info

SI-BONE, Inc. is a medical device company dedicated to solving musculoskeletal disorders of sacropelvic anatomy. The Company specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The Company's products include a series of patented titanium implants, and the instruments used to implant them, as well as implantable bone products. Its products include iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite. Within the United States, iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. Its first-generation iFuse, a machined triangular titanium implant, has a triangular cross section that resists twisting or rotation of the implant. The Company's second generation iFuse product, the iFuse-3D implant, is a patented titanium implant.
Ticker SymbolSIBN
CompanySI-BONE Inc
CEOFrancis (Laura A)
Websitehttps://si-bone.com/
KeyAI